PD-1 COMBINED WITH TRBC1 AND PAN-T CELL ANTIBODIES FOR ROBUSTLY MONITORING ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA


Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach

Abstract The critical function of dihydroorotate dehydrogenase (DHODH) in pyrimidine synthesis attracted a great interest throughout beyond decades.Inhibitors of human DHODH (hDHODH) have validated efficacy for remedy of many immunological diseases.Brequinar and leflunomide are examples of such compounds.However, most of such immunosuppressive medi

read more



Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation

Summary: Health Technology Assessment (HTA) for reimbursement of all new cancer drugs in the European Union (EU) will be evaluated for all member states by a central European HTA starting Chest Freezer in 2025.EU HTA guidelines for applicants under these new regulations put the focus on meta-analysis of aggregated randomized trial data and are in c

read more